Evidence map›Paper›PMID 29713601›Full record

ArticleBioImpacts : BI2018

A novel B- and helper T-cell epitopes-based prophylactic vaccine against

Mohammad M Pourseif, Gholamali Moghaddam, Hossein Daghighkia, Ahmad Nematollahi, Yadollah Omidi

Open access · diamondAbstract read
In one paragraph

Article in BioImpacts : BI, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. miR-378a-5p targeting BRAF regulates CD4Frontiers in immunology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Optimizing sheep B-cell epitopes inFrontiers in immunology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Design of a new multi-epitope vaccine againstEpidemiology and infection · 2021
    Article
  17. Veterinary research forum : an international quarterly journal · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mohammad M PourseifDepartment of Animal Sciences, Faculty of Agriculture, University of Tabriz, Tabriz, Iran.
Gholamali MoghaddamDepartment of Animal Sciences, Faculty of Agriculture, University of Tabriz, Tabriz, Iran.
Hossein DaghighkiaDepartment of Animal Sciences, Faculty of Agriculture, University of Tabriz, Tabriz, Iran.
Ahmad NematollahiDepartment of Pathobiology, Veterinary Collage, University of Tabriz, Tabriz, Iran.
Yadollah OmidiResearch Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0003-0067-2475
University of Tabriz · IRTabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B-cell epitopeEchinococcus granulosusEg14-3-3 antigenLeukocyte antigenT-helper epitopeVaccine

Identifiers

PMID29713601
PMCPMC5915707
OpenAlexW2771580625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.